Allopurinol in Acute Gout

首次发布于 2013 年 1 月 24 日

Colchicine Or Naproxen Treatment for ACute gouT

计划入组 399 人 · 首次发布于 2013 年 11 月 25 日

Pharmacokinetic Study of an Acute Gout Regimen

计划入组 13 人 · 首次发布于 2009 年 11 月 20 日

SNIPR-Gout

Naproxen(Aleve, Aleve PM, Aleve-D, Anaprox, Naprelan, Naprosyn, Sallus, Sudafed Sinus & Pain, Treximet, Vimovo)

C₁₄H₁₄O₃

URAT1 inhibitors (gout)

Scilex Holding

United States

VistaGen Therapeutics

United States

InspireMD

Atom Therapeutics Advances Lingdolinurad into China Phase 3 Trial for Gout, Reports Strong Phase 2b Efficacy Data

Atom Therapeutics Launches Phase 2 Trial of ABP-745 for Atherosclerotic Cardiovascular Disease

Atom Therapeutics' URAT1 Inhibitor Lingdolinurad Meets Primary Endpoint in Phase 2b/3 Chronic Gout Trial